Key result
SafeCross-guided aspiration thrombectomy enables 100% successful Watchman FLX Pro implantation without complications.
Why the study?
There is currently no standard clinical approach to patients needing LAA occlusion device implantation with persistent LAA thrombus.
Does percutaneous balloon-occlusive aspiration thrombectomy using the SafeCross transseptal system facilitate safe and successful LAA thrombus removal and subsequent LAA occlusion device implantation in patients with atrial fibrillation and persistent LAA thrombus?
Case Report (n=4)
No
Does percutaneous balloon-occlusive aspiration thrombectomy using the SafeCross transseptal system facilitate safe and successful LAA thrombus removal and subsequent LAA occlusion device implantation in patients with atrial fibrillation and persistent LAA thrombus?
Answers are grounded in this paper and cite their sources.
This case series demonstrates the novel feasibility and short-term safety of using the steerable, balloon-tipped SafeCross transseptal system for balloon-occlusive aspiration thrombectomy of persistent distal LAA thrombus to enable simultaneous Watchman FLX Pro implantation without requiring large-bore extracorporeal bypass circuits.
BACKGROUND: There is currently no standard clinical approach to patients in need of left atrial appendage (LAA) occlusion device with persistent LAA thrombus. The steerable, balloon-tipped SafeCross transseptal introducer system provides the opportunity for a novel approach to LAA thrombectomy by blockading the LAA os with its balloon tip, creating a closed system for embolic protection during aspiration. CASE SUMMARY: Consecutive patients from the Medical University of South Carolina were included who underwent balloon-occlusive aspiration thrombectomy (BOAT) of the LAA with the SafeCross system followed by LAA occlusion device implantation. DISCUSSION: Four patients, with a mean age of 79.5 ± 4.04 years and 75% male, were included. Balloon occlusion was achieved in 75% of cases during BOAT of the LAA. All cases resulted in successful aspiration of the LAA thrombus and subsequent successful placement of Watchman FLX Pro without periprocedural complications or adverse events at 45-day follow-up. TAKE-HOME MESSAGE: Our small case series demonstrates the feasibility of performing a transseptal LAA BOAT thrombectomy with the SafeCross transseptal system to facilitate LAA occluder implant.
No takes yet. Share an insight, caveat, or question.
Read et al. (2026) conducted a case report in Atrial fibrillation with persistent left atrial appendage (LAA) thrombus and high bleeding risk (n=4). Balloon-occlusive aspiration thrombectomy (BOAT) with the SafeCross transseptal system followed by Watchman FLX Pro LAA occlusion device implantation was evaluated on Successful aspiration of LAA thrombus and subsequent placement of Watchman FLX Pro without periprocedural complications or adverse events at 45-day follow-up. Balloon-occlusive aspiration thrombectomy using the SafeCross system achieved 100% thrombus aspiration and Watchman FLX Pro implantation without complications at 45 days in 4 patients.
Synapse has enriched 10 related papers. Consider them for comparative context: